These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 11750168

  • 1. Comparative antimicrobial activity of gatifloxacin with ciprofloxacin and beta-lactams against gram-positive bacteria.
    Bassetti M, Dembry LM, Farrel PA, Callan DA, Andriole VT.
    Diagn Microbiol Infect Dis; 2001 Nov; 41(3):143-8. PubMed ID: 11750168
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and beta-lactams against gram-positive clinical isolates.
    Bassetti M, Dembry LM, Farrel PA, Callan DA, Andriole VT.
    Antimicrob Agents Chemother; 2002 Jan; 46(1):234-8. PubMed ID: 11751142
    [Abstract] [Full Text] [Related]

  • 3. [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci].
    Hidalgo M, Reyes J, Cárdenas AM, Díaz L, Rincón S, Vanegas N, Díaz PL, Castañeda E, Arias CA.
    Biomedica; 2008 Jun; 28(2):284-94. PubMed ID: 18719726
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.
    Otani T, Tanaka M, Ito E, Kurosaka Y, Murakami Y, Onodera K, Akasaka T, Sato K.
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3750-9. PubMed ID: 14638477
    [Abstract] [Full Text] [Related]

  • 5. In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients.
    Rolston KV, Vaziri I, Frisbee-Hume S, Streeter H, LeBlanc B.
    Chemotherapy; 2004 Nov; 50(5):214-20. PubMed ID: 15523180
    [Abstract] [Full Text] [Related]

  • 6. Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.
    Gradelski E, Kolek B, Bonner DP, Valera L, Minassian B, Fung-Tomc J.
    Int J Antimicrob Agents; 2001 Feb; 17(2):103-7. PubMed ID: 11165113
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD, D'Azevedo PA, Francisco W.
    Cornea; 2007 Feb; 26(2):194-8. PubMed ID: 17251812
    [Abstract] [Full Text] [Related]

  • 8. In-vitro activity of Sch 34343, a new penam, against gram-positive isolates from cancer patients.
    Rolston KV, Alvarez ME, Hoy JF, Alderman HC, Ho DH, Bodey GP.
    J Antimicrob Chemother; 1986 Aug; 18(2):159-62. PubMed ID: 3093447
    [Abstract] [Full Text] [Related]

  • 9. The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria.
    Sefton AM, Maskell JP, Rafay AM, Whiley A, Williams JD.
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():57-62. PubMed ID: 9222071
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998.
    Huczko E, Conetta B, Bonner D, Valera L, Stickle T, Macko A, Fung-Tomc J.
    Int J Antimicrob Agents; 2000 Dec; 16(4):401-5. PubMed ID: 11118848
    [Abstract] [Full Text] [Related]

  • 11. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.
    Duggirala A, Joseph J, Sharma S, Nutheti R, Garg P, Das T.
    Indian J Ophthalmol; 2007 Dec; 55(1):15-9. PubMed ID: 17189881
    [Abstract] [Full Text] [Related]

  • 12. Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates.
    Seifert H.
    Zentralbl Bakteriol; 1998 Dec; 288(4):509-18. PubMed ID: 9987189
    [Abstract] [Full Text] [Related]

  • 13. Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002).
    Fritsche TR, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2003 Oct; 47(2):435-40. PubMed ID: 14522519
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America.
    Jones RN, Beach ML, Pfaller MA, Doern GV.
    Diagn Microbiol Infect Dis; 1998 Nov; 32(3):247-52. PubMed ID: 9884844
    [Abstract] [Full Text] [Related]

  • 15. Comparative killing rates of gatifloxacin and ciprofloxacin against 14 clinical isolates: impact of bacterial strain and antibiotic concentration.
    Pendland SL, Neuhauser MM, Garey KW, Prause JL, Jung R.
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):59-61. PubMed ID: 12376032
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.
    Dalhoff A, Petersen U, Endermann R.
    Chemotherapy; 1996 Sep; 42(6):410-25. PubMed ID: 8957575
    [Abstract] [Full Text] [Related]

  • 17. Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.
    Casellas JM, Tomé G, Bantar C, Bertolini P, Blázquez N, Borda N, Couto E, Cudmani N, Guerrera J, Juárez MJ, López T, Littvik A, Méndez E, Notario R, Ponce G, Quinteros M, Salamone F, Sparo M, Sutich E, Vaylet S, Wolff L.
    Diagn Microbiol Infect Dis; 2003 Nov; 47(3):527-37. PubMed ID: 14596972
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN, Sader HS, Fritsche TR, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.